Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Randomized, Placebo-Controlled Trial of a Chikungunya Virus-Like Particle Vaccine in Healthy Adults
2015-003556-44Phase 2Completed
- Sponsor
- Institut de Médecine et d'Epidémiologie Appliquée
- Start
- Sep 2018
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised trial in Chikungunya (CHIKV) comparing VRC-CHKVLP059-00-VP vaccine with Placebo (2 arms). Primary endpoints: Safety and Neutralizing antibody response at Week 8. Started Sep 2018; status: completed.
02
Drugs
CHIKV VLP vaccine
03
Conditions
Chikungunya (CHIKV)
Beyond the preview
Go deeper on 2015-003556-44.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003556-44.